ArticleSignal transduction and targeted therapy2025

Full-length transcriptome atlas of gallbladder cancer reveals trastuzumab resistance conferred by ERBB2 alternative splicing.

Ziyi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.